Cargando…

How patient participation was used to develop a questionnaire that is fit for purpose for assessing quality of life in severe asthma

BACKGROUND: Previous research shows that existing asthma quality of life questionnaires fail to measure the burden of oral corticosteroids that can be used to treat severe asthma, and are therefore not fit for purpose for severe asthma according to the USA’s Federal Drug Authority’s (FDA) criteria f...

Descripción completa

Detalles Bibliográficos
Autores principales: Hyland, Michael E., Lanario, Joseph W., Pooler, Jill, Masoli, Matthew, Jones, Rupert C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787281/
https://www.ncbi.nlm.nih.gov/pubmed/29374455
http://dx.doi.org/10.1186/s12955-018-0851-9
_version_ 1783295903873892352
author Hyland, Michael E.
Lanario, Joseph W.
Pooler, Jill
Masoli, Matthew
Jones, Rupert C.
author_facet Hyland, Michael E.
Lanario, Joseph W.
Pooler, Jill
Masoli, Matthew
Jones, Rupert C.
author_sort Hyland, Michael E.
collection PubMed
description BACKGROUND: Previous research shows that existing asthma quality of life questionnaires fail to measure the burden of oral corticosteroids that can be used to treat severe asthma, and are therefore not fit for purpose for severe asthma according to the USA’s Federal Drug Authority’s (FDA) criteria for content validity. Patient input and documentation of that input is key to achieving content validity according to FDA guidelines. This paper describes the process of constructing a new questionnaire to measure the burden of asthma symptoms and burden of treatment in severe asthma, using criteria specified by the FDA. METHODS: A draft severe asthma questionnaire (SAQ) was constructed using qualitative input from severe asthma patients who took part in an earlier study. The aim of this study was to improve that draft questionnaire using a further group of patients. In four iterative focus groups, 16 people with severe asthma completed the draft questionnaire, discussed the wording and structure and suggested changes that were incorporated into the final version. RESULTS: The original intention to ask patients to identify whether problems were caused by asthma symptoms or side effects of medication was abandoned as the attribution of cause was found to be difficult and inconsistent. The recall period of 2 weeks was acceptable but fails to reflect the patients’ desire to express the variability of severe asthma. Patients suggested improvements to the wording of the draft questionnaire, including splitting some items in two, combining two items in one, and changes to some of the words in individual items and the response scale. CONCLUSIONS: The final version of the questionnaire was substantially different from one constructed using only qualitative reports from patients about the quality of life deficits of severe asthma. Patients make a valuable contribution to the questionnaire if they are asked to comment and improve an initial draft and where patients are treated as partners in the process of questionnaire construction, rather than only as a source of information to experts who construct the questionnaire.
format Online
Article
Text
id pubmed-5787281
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57872812018-02-08 How patient participation was used to develop a questionnaire that is fit for purpose for assessing quality of life in severe asthma Hyland, Michael E. Lanario, Joseph W. Pooler, Jill Masoli, Matthew Jones, Rupert C. Health Qual Life Outcomes Research BACKGROUND: Previous research shows that existing asthma quality of life questionnaires fail to measure the burden of oral corticosteroids that can be used to treat severe asthma, and are therefore not fit for purpose for severe asthma according to the USA’s Federal Drug Authority’s (FDA) criteria for content validity. Patient input and documentation of that input is key to achieving content validity according to FDA guidelines. This paper describes the process of constructing a new questionnaire to measure the burden of asthma symptoms and burden of treatment in severe asthma, using criteria specified by the FDA. METHODS: A draft severe asthma questionnaire (SAQ) was constructed using qualitative input from severe asthma patients who took part in an earlier study. The aim of this study was to improve that draft questionnaire using a further group of patients. In four iterative focus groups, 16 people with severe asthma completed the draft questionnaire, discussed the wording and structure and suggested changes that were incorporated into the final version. RESULTS: The original intention to ask patients to identify whether problems were caused by asthma symptoms or side effects of medication was abandoned as the attribution of cause was found to be difficult and inconsistent. The recall period of 2 weeks was acceptable but fails to reflect the patients’ desire to express the variability of severe asthma. Patients suggested improvements to the wording of the draft questionnaire, including splitting some items in two, combining two items in one, and changes to some of the words in individual items and the response scale. CONCLUSIONS: The final version of the questionnaire was substantially different from one constructed using only qualitative reports from patients about the quality of life deficits of severe asthma. Patients make a valuable contribution to the questionnaire if they are asked to comment and improve an initial draft and where patients are treated as partners in the process of questionnaire construction, rather than only as a source of information to experts who construct the questionnaire. BioMed Central 2018-01-27 /pmc/articles/PMC5787281/ /pubmed/29374455 http://dx.doi.org/10.1186/s12955-018-0851-9 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Hyland, Michael E.
Lanario, Joseph W.
Pooler, Jill
Masoli, Matthew
Jones, Rupert C.
How patient participation was used to develop a questionnaire that is fit for purpose for assessing quality of life in severe asthma
title How patient participation was used to develop a questionnaire that is fit for purpose for assessing quality of life in severe asthma
title_full How patient participation was used to develop a questionnaire that is fit for purpose for assessing quality of life in severe asthma
title_fullStr How patient participation was used to develop a questionnaire that is fit for purpose for assessing quality of life in severe asthma
title_full_unstemmed How patient participation was used to develop a questionnaire that is fit for purpose for assessing quality of life in severe asthma
title_short How patient participation was used to develop a questionnaire that is fit for purpose for assessing quality of life in severe asthma
title_sort how patient participation was used to develop a questionnaire that is fit for purpose for assessing quality of life in severe asthma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787281/
https://www.ncbi.nlm.nih.gov/pubmed/29374455
http://dx.doi.org/10.1186/s12955-018-0851-9
work_keys_str_mv AT hylandmichaele howpatientparticipationwasusedtodevelopaquestionnairethatisfitforpurposeforassessingqualityoflifeinsevereasthma
AT lanariojosephw howpatientparticipationwasusedtodevelopaquestionnairethatisfitforpurposeforassessingqualityoflifeinsevereasthma
AT poolerjill howpatientparticipationwasusedtodevelopaquestionnairethatisfitforpurposeforassessingqualityoflifeinsevereasthma
AT masolimatthew howpatientparticipationwasusedtodevelopaquestionnairethatisfitforpurposeforassessingqualityoflifeinsevereasthma
AT jonesrupertc howpatientparticipationwasusedtodevelopaquestionnairethatisfitforpurposeforassessingqualityoflifeinsevereasthma